Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Hydrogen sulfide mediates the vasoactivity of garlic
2007 Standout
2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk
2013 Standout
Reactive Oxygen Species in Inflammation and Tissue Injury
2013 Standout
Increased omeprazole metabolism in carriers of the CYP2C19*17 allele; a pharmacokinetic study in healthy volunteers
2008
Homocysteine and vascular disease
1999 Standout
Contrast Medium-Induced Acute Kidney Injury
2015 Standout
Hyperhomocysteinaemia
1999
Cardiovascular Morbidity and Mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in Chronic Renal Failure
2006
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
2013 Standout
Hyperhomocysteinemia in terms of steady-state kinetics
1998
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
2002 Standout
Abnormal cardiac function in the streptozotocin-induced, non–insulin-dependent diabetic rat
1999
Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging
2013 Standout
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
2008 Standout
The right ventricle: anatomy, physiology, and clinical importance
1991
Oral Anticoagulant Therapy
2012 Standout
Coffee consumption and plasma total homocysteine: The Hordaland Homocysteine Study
1997
Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuria
1999
Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function
2012
Degradable metallic biomaterials: Design and development of Fe–Mn alloys for stents
2009
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
Efflux-mediated heavy metal resistance in prokaryotes
2003 Standout
Cardiac calcification in adult hemodialysis patients
2002 Standout
Serum homocysteine level and protein intake are related to risk of microalbuminuria: The Hoorn Study
1998
Neural-Tube Defects
1999 Standout
Susceptibility to spina bifida; an association study of five candidate genes
1998
Chemistry, Biochemistry, and Safety of Acrylamide. A Review
2003 Standout
Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: the Hordaland Homocysteine Study
1999
A new HPLC method for the simultaneous determination of oxidized and reduced plasma aminothiols using coulometric electrochemical detection
1999
Kinetics of omeprazole and escitalopram in relation to the CYP2C19*17 allele in healthy subjects
2008
Homocysteine and cardiovascular disease: cause or effect?
2000
Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects
2007
The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors
2002 Standout
Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17
2009
The versatility and universality of calcium signalling
2000 Standout
Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population
2008 Nature
Contrast-induced kidney injury: mechanisms, risk factors, and prevention
2012
CYP2C9 Genotype-guided Warfarin Prescribing Enhances the Efficacy and Safety of Anticoagulation: A Prospective Randomized Controlled Study
2007
Fluorescent and colorimetric probes for detection of thiols
2010 Standout
Change from three times a week on-line hemodiafiltration to short daily on-line hemodiafiltration
2003
Poor Long-Term Survival After Coronary Angiography in Patients With Renal Insufficiency
2001
Diet, nutrition and the prevention of hypertension and cardiovascular diseases
2004
Maternal and child undernutrition: global and regional exposures and health consequences
2008 Standout
Modified Mediterranean Diet for Enrichment of Short Chain Fatty Acids: Potential Adjunctive Therapeutic to Target Immune and Metabolic Dysfunction in Schizophrenia?
2017
‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*
2003 Standout
Cardiorenal Syndrome
2008 Standout
Homocysteine and Risk of Ischemic Heart Disease and Stroke
2002 Standout
Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation
2008
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients
2002 Standout
Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes
1997
The role of short-chain fatty acids in microbiota–gut–brain communication
2019 Standout
Pharmacogenetics of Antidepressants
2011
Pre-eclampsia
2010 Standout
Computed tomography for assessment of cardiac chambers, valves, myocardium and pericardium
2003
Induction and Enhancement of Cardiac Cell Differentiation from Mouse and Human Induced Pluripotent Stem Cells with Cyclosporin-A
2011 StandoutNobel
Plasma total cysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine Study
2003
Hyperhomocysteinemia, Pregnancy Complications, and the Timing of Investigation
2004
Normal and Pathologic Concentrations of Uremic Toxins
2012 Standout
Albuminuria and Risk of Cardiovascular Events, Death, and Heart Failure in Diabetic and Nondiabetic Individuals
2001 Standout
From evidence based medicine to mechanism based medicine. Reviewing the role of pharmacogenetics
2010
iPS cells: A source of cardiac regeneration
2010 StandoutNobel
5, 10-Methylenetetrahydrofolate Reductase Gene Variants and Congenital Anomalies: A HuGE Review
2000
Folate and human reproduction
2006
Occludin oligomeric assembly at tight junctions of the blood‐brain barrier is disrupted by peripheral inflammatory hyperalgesia
2008
Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis
2011
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
PharmGKB summary
2011
Influence of the viscosity of iodixanol on medullary and cortical blood flow in the rat kidney: a potential cause of nephrotoxicity
1999
Clinical significance of pharmacological modulation of homocysteine metabolism
1990
Homocysteine and Atherothrombosis
1998 Standout
Identification of CYP2C19*4B: pharmacogenetic implications for drug metabolism including clopidogrel responsiveness
2011
Clinical Application of CYP2C19 Pharmacogenetics Toward More Personalized Medicine
2013
Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography
2010 Standout
DNA Microarray Technology in the Clinical Environment:The AmpliChip CYP450 Test for CYP2D6 and CYP2C19 Genotyping
2009
Efficient and Scalable Purification of Cardiomyocytes from Human Embryonic and Induced Pluripotent Stem Cells by VCAM1 Surface Expression
2011 StandoutNobel
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography
2009 Standout
The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells
2009 StandoutNobel
Development of new metallic alloys for biomedical applications
2012 Standout
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Directed and Systematic Differentiation of Cardiovascular Cells From Mouse Induced Pluripotent Stem Cells
2008 StandoutNobel
Right ventricular diastolic pressure-volume relations and regional dimensions during acute alterations in loading conditions.
1988
Luminescent Chemodosimeters for Bioimaging
2012 Standout
Common Methylenetetrahydrofolate Reductase Gene Mutation Leads to Hyperhomocysteinemia but Not to Vascular Disease
1998
Assessing Plasma Total Homocysteine in Patients with End-Stage Renal Disease
2007
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008 Standout
Pharmacogenomics of Tamoxifen Therapy
2009
Serum Total Homocysteine Concentrations in the Third National Health and Nutrition Examination Survey (1991–1994): Population Reference Ranges and Contribution of Vitamin Status to High Serum Concentrations
1999
Contrast Media Viscosity versus Osmolality in Kidney Injury: Lessons from Animal Studies
2014
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Homocysteine and Thrombotic Disease
1997
Guidelines for the Primary Prevention of Stroke
2014 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Metabolism of Homocysteine Thiolactone in Human Cell Cultures
1997
Recent Stem Cell Advances: Induced Pluripotent Stem Cells for Disease Modeling and Stem Cell–Based Regeneration
2010 StandoutNobel
Fiber Types in Mammalian Skeletal Muscles
2011 Standout
Elevated Fasting Total Plasma Homocysteine Levels and Cardiovascular Disease Outcomes in Maintenance Dialysis Patients
1997
Mechanisms of Diabetic Complications
2013 Standout
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
Potential Therapeutic Applications of MnSODs and SOD‐Mimetics
2017
Homocysteine and Cardiovascular Disease
1998 Standout
Sodium/Calcium Exchange: Its Physiological Implications
1999 Standout
Estimation of left ventricular operating stiffness from Doppler early filling deceleration time in humans
2001
Nonfasting Plasma Total Homocysteine Level and Mortality in Middle-Aged and Elderly Men and Women in Jerusalem
1999
Plasma homocysteine in children with acute lymphoblastic leukemia: changes during a chemotherapeutic regimen including methotrexate.
1991
Works of H. Refsum being referenced
Serum concentrations of risperidone and 9‐OH risperidone following intramuscular injection of long‐acting risperidone compared with oral risperidone medication
2006
Serum concentrations of sertraline and N-desmethyl sertraline in relation to CYP2C19 genotype in psychiatric patients
2008
Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure
1997
The Hordaland Homocysteine Study: The Opposite Tails Odds Ratios Reveal Differential Effects of Gender and Intake of Vitamin Supplements at High and Low Plasma Total Homocysteine Concentrations
1996
Impact of the Ultrarapid CYP2C19*17 Allele on Serum Concentration of Escitalopram in Psychiatric Patients
2007
The haemodynamic effects of iodinated water soluble radiographic contrast media: a review
1998
The Complexity of Active Metabolites in Therapeutic Drug Monitoring of Psychotropic Drugs
2006
Cardioangiography and the Hemodynamic Effects of Iodixanol
1995
Sodium-Calcium Relationships and Cardiac Function during Coronary Bolus Perfusion
1995
Cardioprotective effects of the MR contrast agent MnDPDP and its metabolite MnPLED upon reperfusion of the ischemic porcine myocardium
2001
Cardioprotective effects of the MR contrast agent MnDPDP and its metabolite MnPLED upon reperfusion of the ischemic porcine myocardium
2001
A Comparison Between the Information in Gated and Nongated Cardiac CT Images
1982
Contributions of a transient outward current to repolarization in human atrium
1989
Disposition of Endogenous Homocysteine by Mouse Fibroblast C3H/10T1/2 CI 8 and the Chemically Transformed C3H/10T1/2 MCA CI 16 Cells Following Methotrexate Exposure<xref ref-type="fn" rid="FN1">2</xref>
1986
Cardiovascular safety of MnDPDP and MnCl2
1997
Ventricular diastolic pressure-volume relations and the pericardium. Effects of changes in blood volume and pericardial effusion in dogs.
1981
Elevated plasma total homocysteine and C677T mutation of the methylenetetrahydrofolate reductase gene in patients with spina bifida
1997
Quantification of effect of pericardium on LV diastolic PV relation in dogs
1987
Association between serum lipids and membrane fatty acids and clinical characteristics in patients with schizophrenia
2015